Sat.Aug 27, 2022 - Fri.Sep 02, 2022

article thumbnail

Parexel joins pharmacy giants in quest to boost community health clinical trials

PharmaVoice

The Community Alliance Network is the latest industry initiative looking to the pharmacy counter to help improve trial recruitment diversity.

299
299
article thumbnail

Your questions on the new Covid vaccine boosters answered

STAT

Sometime this weekend or early next week, pharmacies and doctors’ offices are going to start to receive Covid-19 boosters that have been reformulated to include protection against one of the sub-variants of Omicron. These boosters, from Pfizer and its partner BioNTech as well as from Moderna, are bivalent shots. They target two strains of the SARS-CoV-2 virus, both the original strain that all previous vaccines have protected against, and the Omicron sub-variants BA.4/BA.5.

Vaccines 291
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Green light for cancer drugs developed by AI specialist Owkin

Pharma Times

AI company has its breast cancer and colorectal therapies approved for use in Europe

article thumbnail

What is a 340B covered entity?

PhRMA

We are committed to engaging a wide range of audiences and having a dialogue on opportunities to create a better health care system. We believe health literacy can not only help patients make appropriate decisions about their own health but also help enable constructive conversations on how we can support a regulatory and policy environment that helps patients access life-saving medications.

122
122
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Hurdles remain in biosims market — but Alvotech is undeterred

PharmaVoice

The biosimilar developer is advancing a pipeline with high growth potential, including a copycat of Humira.

article thumbnail

Opinion: As hospitals raise their prices, U.S. workers and businesses suffer

STAT

Despite a recent taxpayer-subsidized boon , the hospital industry spent the last several months lobbying for additional federal dollars amid warnings about the continued spread of Covid-19 and inflation’s impact on the nation’s health care system. Those efforts bore fruit: Medicare recently granted hospitals the largest price increase since 1998.

Hospitals 255

More Trending

article thumbnail

Managing the next pandemic: the role of nasal vaccine administration

European Pharmaceutical Review

The COVID-19 pandemic has reminded the pharmaceutical industry of several key lessons. It has highlighted the value of cutting-edge technologies, such as messenger RNA (mRNA) vaccines, and reinforced the industry’s understanding of the power of collaboration, including with contract partners such as contract development and manufacturing organisations (CDMOs).

Vaccines 119
article thumbnail

Woman of the Week: Thread’s Kim Boericke

PharmaVoice

Fresh off an eight-year tour of duty at ICON, the CRO industry veteran is stepping into a new role and a new title as chief delivery officer at Thread.

246
246
article thumbnail

Rahul Gupta, first physician to serve as drug czar, says stigma among doctors is key culprit in addiction crisis

STAT

WASHINGTON — Rahul Gupta is no stranger to the nationwide addiction crisis. Drug use and overdose defined his tenure as the top health official in West Virginia, arguably the state hardest hit by the epidemic, and before that as the health officer in the state’s largest county.

246
246
article thumbnail

Manus Bio receives additional funding to combat malaria

Pharma Times

Fourth award from the Bill & Melinda Gates Foundation will support artemisinin research

123
123
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

3D printing of starch-based tablets for personalised drug delivery

European Pharmaceutical Review

Researchers from UPV/EHU-University of the Basque Country, Spain, have successfully produced different types of starch-based pharmaceutical tablets using 3D printing. The aim of the study, published in the International Journal of Pharmaceutics , was to produce 3D printed starch-based tablets for the tailored delivery of hydrophobic drugs. Hydrophobic drugs – those that poorly water soluble – account for some 40% of marketed drugs and the 60% of the drug candidates in research, the paper notes.

118
118
article thumbnail

Leading the industry’s next potential game-changer in drug discovery

PharmaVoice

Rachel Meyers, chief scientific officer at Faze Medicines, is helping guide the company towards the development of biomolecular condensates — an emerging field that could transform drug discovery.

246
246
article thumbnail

Opinion: Prediction markets and the future of Covid-19

STAT

Forecasters have used all sorts of tools to gauge where the U.S. and the world are headed with Covid-19, ranging from epidemiologic models to historical ones. Here’s another possibility: prediction markets. Prediction markets use a wisdom of crowds approach to aggregate beliefs and predict future outcomes. They typically function through bets in futures contracts that pay out on expiration of defined “yes or no” outcomes.

246
246
article thumbnail

Psyomics links up with Hertfordshire Partnership University NHS Foundation Trust

Pharma Times

Hertfordshire Trust to invest in mental health care with wide-ranging digital assessment platform

123
123
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

EMCrit Wee – Sleep Part 1 – Shift Work Strategies with Mike and Mike from Wild Health

EMCrit Project

Sleep for Shift Workers--this info may add years to your life and keep you performing optimally. EMCrit Project by Scott Weingart, MD FCCM.

117
117
article thumbnail

The ‘long COVID’ nightmare: Data-driven alliance offers understanding of the lasting viral impact

PharmaVoice

A collaboration between Stanford University researchers and Komodo Health aims to advance knowledge of lingering COVID symptoms, health disparities and intervention strategies.

246
246
article thumbnail

Opinion: ‘Food is medicine’ interventions should be the main course at White House nutrition conference

STAT

Much of the public’s perceptions around food as an intervention for health are dated. So are the U.S. government’s perceptions and its health care policies. Not by a matter of years, but by decades. The last time the nation focused on food — from the top — was the 1969 White House Conference on Food, Nutrition, and Health.

Labelling 246
article thumbnail

European Commission approves pharma trio’s Ranivisio

Pharma Times

Therapy is a biosimilar of Lucentis which treats several serious retinal diseases across the European Union

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Novartis extends Kaiku digital patient monitoring partnership

pharmaphorum

Kaiku Health’s year-old alliance with Novartis to develop a digital patient monitoring and management (DPPM) system for patients with melanoma is being extended, according to the two partners. The original agreement last year focused on melanoma patients who are receiving BRAF/MEK combination therapies – specifically Novartis’ Tafinlar (dabrafenib) and Mekinist (trametinib) drugs – and has resulted in the development of a digital module tailored to their needs.

article thumbnail

First 90 Days: Adaptive Biotech’s Tycho Peterson

PharmaVoice

A long-time analyst, Tycho Peterson brings his business savvy to the C-suite at Adaptive, where he began as CFO in June with a knowledge of what works and what doesn't in the diagnostics space.

243
243
article thumbnail

Opinion: Public health needs to be transformed. Health IT can help

STAT

Covid-19 pummeled public health agencies and organizations. Future crises, whether from infectious disease, extreme weather, or other sources, are likely to do the same unless they change their approach to public health reporting, data management, and information exchange. Managing public health is not easy, especially in the United States. Not only is this country home to diverse populations that have varying genetic predispositions and cultural patterns of medical significance, it is also geog

246
246
article thumbnail

First patient enrolled in Modus’ sevuparin trial

Pharma Times

Research is evaluating the therapy among paediatric patients with severe malaria

123
123
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

CMS coverage policies restrict patient access to important treatment options for Alzheimer’s disease

PhRMA

There’s been a lot of discussion this year about the Centers for Medicare & Medicaid Services (CMS) national coverage determination (NCD) for new Alzheimer’s treatments finalized earlier this year in April. Their policy, finalized this past April, puts in place barriers between Alzheimer’s patients in Medicare and potentially life-changing treatment.

107
107
article thumbnail

Pharma’s renewed sickle cell investment lifts a once-shirked disease

PharmaVoice

Pfizer's $5.4 billion deal to acquire Global Blood Therapeutics invigorated the fast-growing market, and patients are fit to be the benefactors.

147
147
article thumbnail

Listen: The anti-aging research boom, the Godfather of biotech, & the future of Biogen

STAT

What can worms teach us about immortality? How does one become the Godfather? And where does Biogen go from here? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the scientific discoveries, rampant hype, and Silicon Valley billions behind the burgeoning field of longevity research.

246
246
article thumbnail

Kaiku Health enters wider partnership with Novartis

Pharma Times

Following a successful collaboration, the companies will now partner to focus on precision medicine

123
123
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Novo Nordisk agrees to acquire biopharma firm Forma for $1.1bn

Pharmaceutical Technology

Novo Nordisk has signed a definitive agreement for the acquisition of clinical-stage biopharmaceutical firm Forma Therapeutics for $20 for each share in cash or a total equity price of $1.1bn. Forma focuses on researching, developing and marketing new therapies for patients with sickle cell disease (SCD), rare hematologic diseases and cancers. Through the acquisition, Novo Nordisk plans to boost its presence in sickle cell disease and rare blood disorders.

105
105
article thumbnail

Why high-quality medical translations can help save lives

PharmaVoice

Crystal clear communication is becoming more important for businesses working in our increasingly connected world.

article thumbnail

STAT+: Illumina wins case against FTC in bid to hold onto early cancer detection company Grail

STAT

SAN DIEGO — Sequencing behemoth Illumina on Thursday won its case against the Federal Trade Commission in its bid to hold onto Grail, a Bay Area early cancer detection company that the genomics giant acquired for $8 billion last year. An administrative law judge rejected the FTC’s argument that the San Diego company’s acquisition of Grail would quash competition in the nascent market for multi-cancer early detection, a technology that picks up on a wide range of cancer types

246
246
article thumbnail

Avacta announces clinical study of AVA6000

Pharma Times

Pro-doxorubicin will advance to the fourth dose following a positive review of safety and tolerability

123
123
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.